Spectra Optia Apheresis System (intended to be used to separate blood extracted from a donor or patient into various components, while the donor/patient is connected to the unit) 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Terumo BCT Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2015-RN-00862-1
  • 사례 위험등급
    Class I
  • 사례 시작날짜
    2015-09-04
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    There have been reports of data entry errors that cause the system to calculate a patient total blood volume (tbv) that is abnormal for that specific patient. the error can occur under the following circumstances: ? the operator accidentally switches the values for height and weight when entering the data. ? the patient is weighed and measured in units that are different from what the operator selects when entering the data. ? the operator enters a height and a weight that are not accurate. if the operator does not enter correct data, the patient may receive excess anticoagulant (ac) or the outcome of the procedure may be affected. this issue can have the greatest effect on small or compromised patients for whom an abnormally high tbv calculation could lead to hypocalcemia.
  • 조치
    Terumo BCT is reminding all users to verify that the entered height, weight and calculated TBV are correct in order to mitigate this risk. Instructions for use and confirmation screens are displayed on the system screens before the operator starts the procedure. In addition, Terumo is developing modifications to the Spectra Optia system software to further mitigate the potential for data entry errors. When the software is available, it will be installed during a scheduled preventive maintenance visit. This action has been closed-out on 02/05/2017.

Device

  • 모델명 / 제조번호(시리얼번호)
    Spectra Optia Apheresis System (intended to be used to separate blood extracted from a donor or patient into various components, while the donor/patient is connected to the unit)ARTG Number: 130529
  • 의료기기 분류등급
  • Manufacturer

Manufacturer